Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure

Impaired glucose metabolism and its consequence diabetes mellitus is still challenging the health care system worldwide. According to the International Diabetes Federation in 2021, the number of adult people living with diabetes was approximately 537 million and 860 million adults had prediabetes. I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mirzazada, Valeh, Sultanova, Sadagat, Ismayilova, Natavan, Huseynova, Aygun, Nurmammadova, Gulnara, Ismayilova, Sevil, Aliyeva, Aygun
Formato: Capítulo de libro
Lenguaje:inglés
Publicado: IntechOpen 2022
Materias:
Acceso en línea:https://www.intechopen.com/chapters/83321
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1879164795485159424
author Mirzazada, Valeh
Sultanova, Sadagat
Ismayilova, Natavan
Huseynova, Aygun
Nurmammadova, Gulnara
Ismayilova, Sevil
Aliyeva, Aygun
author_browse Aliyeva, Aygun
Huseynova, Aygun
Ismayilova, Natavan
Ismayilova, Sevil
Mirzazada, Valeh
Nurmammadova, Gulnara
Sultanova, Sadagat
author_facet Mirzazada, Valeh
Sultanova, Sadagat
Ismayilova, Natavan
Huseynova, Aygun
Nurmammadova, Gulnara
Ismayilova, Sevil
Aliyeva, Aygun
author_sort Mirzazada, Valeh
building IntechOpen
collection Acceso abierto
description Impaired glucose metabolism and its consequence diabetes mellitus is still challenging the health care system worldwide. According to the International Diabetes Federation in 2021, the number of adult people living with diabetes was approximately 537 million and 860 million adults had prediabetes. It is predicted that numbers will rise in the future. Numerous researches have shown that prediabetes and diabetes mellitus are serious risk factors for cardiovascular diseases. Lots of epidemiological evidence figured out that diabetes mellitus is associated with the risk of developing heart failure. Diabetes mellitus is highly prevalent among patients with heart failure. Moreover, several anti-diabetics (anti-prediabetic) medications are contributing their share into developing heart failure by increasing risk of mortality and hospitalization for heart failure. This chapter will discuss the connection between prediabetes, diabetes mellitus, and chronic heart failure.
doi_str_mv 10.5772/intechopen.106391
first_indexed 2026-10-15T21:40:01Z
format Book Chapter
fullrecord <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>intech-83321</identifier><datestamp>2022-08-27</datestamp> <dc:title>Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure</dc:title> <dc:creator>Valeh Mirzazada</dc:creator> <dc:creator>Sadagat Sultanova</dc:creator> <dc:creator>Natavan Ismayilova</dc:creator> <dc:creator>Aygun Huseynova</dc:creator> <dc:creator>Gulnara Nurmammadova</dc:creator> <dc:creator>Sevil Ismayilova</dc:creator> <dc:creator>Aygun Aliyeva</dc:creator> <dc:subject>Health Sciences</dc:subject> <dc:description>Impaired glucose metabolism and its consequence diabetes mellitus is still challenging the health care system worldwide. According to the International Diabetes Federation in 2021, the number of adult people living with diabetes was approximately 537 million and 860 million adults had prediabetes. It is predicted that numbers will rise in the future. Numerous researches have shown that prediabetes and diabetes mellitus are serious risk factors for cardiovascular diseases. Lots of epidemiological evidence figured out that diabetes mellitus is associated with the risk of developing heart failure. Diabetes mellitus is highly prevalent among patients with heart failure. Moreover, several anti-diabetics (anti-prediabetic) medications are contributing their share into developing heart failure by increasing risk of mortality and hospitalization for heart failure. This chapter will discuss the connection between prediabetes, diabetes mellitus, and chronic heart failure.</dc:description> <dc:publisher>IntechOpen</dc:publisher> <dc:date>2022-08-27</dc:date> <dc:type>Chapter, Part Of Book</dc:type> <dc:identifier>https://www.intechopen.com/chapters/83321</dc:identifier> <dc:identifier>doi:10.5772/intechopen.106391</dc:identifier> <dc:language>en</dc:language> <dc:relation>ISBN:978-1-80356-116-5</dc:relation> <dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights> <dc:source>https://www.intechopen.com/books/11739 ; Novel Pathogenesis and Treatments for Cardiovascular Disease</dc:source> </oai_dc:dc>
id intech-83321
institution IntechOpen
isbn 978-1-80356-116-5
language English
last_indexed 2026-10-15T21:40:01Z
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher IntechOpen
publisherStr IntechOpen
record_format oai_dc
spelling intech-833212022-08-27 Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure Valeh Mirzazada Sadagat Sultanova Natavan Ismayilova Aygun Huseynova Gulnara Nurmammadova Sevil Ismayilova Aygun Aliyeva Health Sciences Impaired glucose metabolism and its consequence diabetes mellitus is still challenging the health care system worldwide. According to the International Diabetes Federation in 2021, the number of adult people living with diabetes was approximately 537 million and 860 million adults had prediabetes. It is predicted that numbers will rise in the future. Numerous researches have shown that prediabetes and diabetes mellitus are serious risk factors for cardiovascular diseases. Lots of epidemiological evidence figured out that diabetes mellitus is associated with the risk of developing heart failure. Diabetes mellitus is highly prevalent among patients with heart failure. Moreover, several anti-diabetics (anti-prediabetic) medications are contributing their share into developing heart failure by increasing risk of mortality and hospitalization for heart failure. This chapter will discuss the connection between prediabetes, diabetes mellitus, and chronic heart failure. IntechOpen 2022-08-27 Chapter, Part Of Book https://www.intechopen.com/chapters/83321 doi:10.5772/intechopen.106391 en ISBN:978-1-80356-116-5 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/11739 ; Novel Pathogenesis and Treatments for Cardiovascular Disease
spellingShingle Health Sciences
Mirzazada, Valeh
Sultanova, Sadagat
Ismayilova, Natavan
Huseynova, Aygun
Nurmammadova, Gulnara
Ismayilova, Sevil
Aliyeva, Aygun
Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure
title Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure
title_full Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure
title_fullStr Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure
title_full_unstemmed Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure
title_short Diabetes Mellitus Type 2, Prediabetes, and Chronic Heart Failure
title_sort diabetes mellitus type 2 prediabetes and chronic heart failure
topic Health Sciences
url https://www.intechopen.com/chapters/83321
work_keys_str_mv AT mirzazadavaleh diabetesmellitustype2prediabetesandchronicheartfailure
AT sultanovasadagat diabetesmellitustype2prediabetesandchronicheartfailure
AT ismayilovanatavan diabetesmellitustype2prediabetesandchronicheartfailure
AT huseynovaaygun diabetesmellitustype2prediabetesandchronicheartfailure
AT nurmammadovagulnara diabetesmellitustype2prediabetesandchronicheartfailure
AT ismayilovasevil diabetesmellitustype2prediabetesandchronicheartfailure
AT aliyevaaygun diabetesmellitustype2prediabetesandchronicheartfailure